Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -0.757\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a.) Cc1ccc(Nc2nc(N)nc(CSC(=S)N3CCOCC3)n2)cc1
b.) CCOCCN1CCN(c2c(C)c(C)nc3cc(-c4cc(OC)cc(OC)c4)nn23)CC1
c.) O=S(=O)(c1cccs1)N1CCC2(CC1)OCCN2S(=O)(=O)c1ccccc1
d.) COc1ccc(S(=O)(=O)N2CCN(Cc3cccc([N+](=O)[O-])c3)CC2)cc1
e.) CCOc1ccc(N2C(=O)C(c3ccccc3)=C(c3nc4ccccc4s3)C2NC(C)=O)cc1
Answer: a. Cc1ccc(Nc2nc(N)nc(CSC(=S)N3CCOCC3)n2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(Nc2nc(N)nc(CSC(=S)N3CCOCC3)n2)cc1
Cc1ccc(Nc2nc(N)nc(CSC(=S)N3CCOCC3)n2)cc1
[4-amino-6-(4-methylanilino)-1,3,5-triazin-2-yl]methyl morpholine-4-carbodithioate